Product Program year 2022 Source: CMS Open Payments

Alkindi

Drug Replacement therapy for pediatric patients with AI (ALKINDI SPRINKLE PI)

NDC 71863-109-50

Open in the dashboard

General payments

$2,050

290 payments

Research payments

$0

0 payments

Through program year 2022, $2,050 in general payments and $0 in research payments were reported against Alkindi (Replacement therapy for pediatric patients with AI (ALKINDI SPRINKLE PI)).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2022 General $2,050 290

Breakdown

Who paid General payments · program year 2022
  1. TOLMAR Pharmaceuticals, Inc. $2,050 290 payments
Top recipients General payments · program year 2022
  1. Amy Burton Pediatric Endocrinology · Plano, TX $118 6% · 24 payments
  2. Shamita Trivedi Endocrinology, Diabetes & Metabolism · Dallas, TX $100 5% · 24 payments
  3. Jennifer Kyllo Pediatric Endocrinology · St Paul, MN $80 4% · 33 payments
  4. Naznin Dixit Pediatric Endocrinology · Jackson, MS $45 2% · 2 payments
  5. Simeen Pasha Pediatric Endocrinology · Jackson, MS $45 2% · 2 payments

The top 5 of 92 recipients; each share is of general payments naming this product in 2022.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2022
  1. Pediatric Endocrinology Pediatrics $1,261 62% · 56 practitioners
  2. Endocrinology, Diabetes & Metabolism Internal Medicine $175 9% · 4 practitioners
  3. Nurse Practitioner, Pediatrics Nurse Practitioner $149 7% · 9 practitioners
  4. Physician Assistant $137 7% · 6 practitioners
  5. Nurse Practitioner, Family Nurse Practitioner $97 5% · 4 practitioners

The top 5 of 11 specialties; each share is of general payments naming this product to practitioners with a specialty in 2022. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2022
  1. Texas $347 17% · 7 recipients
  2. Arizona $320 16% · 13 recipients
  3. Florida $226 11% · 13 recipients
  4. California $173 8% · 9 recipients
  5. Mississippi $168 8% · 5 recipients

The top 5 of 22 states; each share is of general payments naming this product in 2022 where a state was reported.

The top 25 states, free in the app

290 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2022

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record